Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm, Rectum”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02830633
What this trial is testing

Trial to Evaluate Laparoscopy-assisted Nerve-preserved Total Mesorectal Excision (LNTME) Versus Open TME for Rectal Cancer

Who this might be right for
Rectal Cancer
Anhui Medical University 80
Post-approval studies (Phase 4)UnknownNCT04747951
What this trial is testing

Total Neoadjuvant Therapy in Rectal Cancer Treatment

Who this might be right for
Rectal Cancer
State Scientific Centre of Coloproctology, Russian Federation 280
Not applicableLooking for participantsNCT04936581
What this trial is testing

Patient Reported Outcomes Following Cancer of the Rectum

Who this might be right for
Sphincter Ani IncontinenceRectal Cancer
University Hospital Gregorio Marañón 200
Not applicableLooking for participantsNCT05696002
What this trial is testing

Advanced Pelvic Surgical Oncology Database - Prospective Observational Study

Who this might be right for
Rectal CancerPelvic CancerGynecologic Cancer+1 more
Glasgow Royal Infirmary 300
Not applicableNot Yet RecruitingNCT06528353
What this trial is testing

Blood Biomarkers Based Screening for HPV-driven OPC

Who this might be right for
Head and Neck Squamous Cell CarcinomaAnal CancerHuman Papilloma Virus
UNICANCER 10,000
Not applicableNot Yet RecruitingNCT06616870
What this trial is testing

Study of the Predictive and Prognostic Role of Pharmacogenetic and Radiogenic Variants on the Response to Neoadjuvant Chemoradiation Therapy in Patients With Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer
Centro di Riferimento Oncologico - Aviano 460
Not applicableLooking for participantsNCT07296237
What this trial is testing

Beyond Survival: Addressing Gynecological and Sexual Health in Women After Radiotherapy for Anal Cancer

Who this might be right for
Anal Cancer
Aarhus University Hospital 80
Testing effectiveness (Phase 2)UnknownNCT06395337
What this trial is testing

Multimodal Imaging in Rectal Cancer & Pancreatic Cancer

Who this might be right for
Rectal CancerPancreatic Cancer
Radboud University Medical Center 20
Testing effectiveness (Phase 2)Ended earlyNCT00006037
What this trial is testing

Chemotherapy Plus IM-862 in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
University of Southern California 18
Testing effectiveness (Phase 2)Looking for participantsNCT07458529
What this trial is testing

Neoadjuvant Chemoradiotherapy Plus Tislelizumab With or Without Probio-M9 in pMMR/MSS Locally Advanced Rectal Cancer

Who this might be right for
Rectal Cancer, AdenocarcinomaNeoadjuvant TherapyImmunotherapy+3 more
Seventh Medical Center of PLA General Hospital 50
Not applicableActive Not RecruitingNCT05245331
What this trial is testing

Transanal Irrigation for Low Anterior Resection Syndrome.

Who this might be right for
Low Anterior Resection Syndrome
Hospital Universitari de Bellvitge 20
Not applicableStudy completedNCT01511653
What this trial is testing

Validation of Colon Biomarkers for the Early Detection of Colorectal Adenocarcinoma

Who this might be right for
Colon CancerRectal Cancer
University of Michigan 13,000
Testing effectiveness (Phase 2)Study completedNCT00504153
What this trial is testing

Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal Cancer

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IV Colon Cancer+1 more
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Study completedNCT00303875
What this trial is testing

Exercise and Dietary Counseling in Improving Physical Activity, Nutrition, and Quality of Life in Older Long-Term Cancer Survivors Who Are Overweight

Who this might be right for
Breast CancerColorectal CancerProstate Cancer
Duke University 641
Not applicableLooking for participantsNCT06052332
What this trial is testing

Efficacy and Safety of Conventional Neoadjuvant Therapy Versus Total Neoadjuvant Therapy in Older Patients With Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal CancerOlder People
Jules Bordet Institute 230
Testing effectiveness (Phase 2)Ended earlyNCT02010567
What this trial is testing

Neoadjuvant Chemoradiotherapy With CRLX-101 and Capecitabine for Rectal Cancer

Who this might be right for
Rectal Cancer
UNC Lineberger Comprehensive Cancer Center 32
Not applicableStudy completedNCT01170299
What this trial is testing

Low-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal Cancer

Who this might be right for
Anal CancerBladder CancerCervical Cancer+6 more
Royal Marsden NHS Foundation Trust 177
Large-scale testing (Phase 3)Active Not RecruitingNCT04246684
What this trial is testing

Short RT Versus RCT,Followed by Chemo and Organ Preservation for Interm and High-risk Rectal Cancer Patients

Who this might be right for
Rectal Cancer Stage III
Prof. Dr. med. Claus Rödel 702
Large-scale testing (Phase 3)Not Yet RecruitingNCT07321847
What this trial is testing

Injection of IP-001 Into Thermally Ablated Hepatic Tumors in Patients With Colorectal Liver Metastases

Who this might be right for
Colorectal Cancer (CRC)Colon Cancer Liver MetastasesRectal Cancer+2 more
Immunophotonics, Inc. 717
Testing effectiveness (Phase 2)Ended earlyNCT00677612
What this trial is testing

Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer

Who this might be right for
Colorectal CancerColon CancerRectal Cancer
Tokyo University 14
Next Page